<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1679-4974</journal-id>
<journal-title><![CDATA[Epidemiologia e Serviços de Saúde]]></journal-title>
<abbrev-journal-title><![CDATA[Epidemiol. Serv. Saúde]]></abbrev-journal-title>
<issn>1679-4974</issn>
<publisher>
<publisher-name><![CDATA[Secretaria de Vigilância em Saúde e Ambiente - Ministério da Saúde do Brasil]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1679-49742022000100703</article-id>
<article-id pub-id-type="doi">10.1590/s1679-49742022000100020</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Hesitação vacinal contra a COVID-19 em amostra nacional de idosos brasileiros: iniciativa ELSI-COVID, março de 2021]]></article-title>
<article-title xml:lang="es"><![CDATA[Hesitación vacunal contra el COVID-19 en una muestra nacional de ancianos brasileños: iniciativa ELSI-COVID, marzo de 2021]]></article-title>
<article-title xml:lang="en"><![CDATA[COVID-19 vaccine hesitancy in a national sample of older Brazilians: the ELSI-COVID Initiative, March 2021]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lima-Costa]]></surname>
<given-names><![CDATA[Maria Fernanda]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Macinko]]></surname>
<given-names><![CDATA[James]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mambrini]]></surname>
<given-names><![CDATA[Juliana Vaz de Melo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Fundação Instituto Oswaldo Cruz Instituto René Rachou ]]></institution>
<addr-line><![CDATA[Belo Horizonte MG]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,University of California Fielding School of Public Health ]]></institution>
<addr-line><![CDATA[Los Angeles CA]]></addr-line>
<country>USA</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<volume>31</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_arttext&amp;pid=S1679-49742022000100703&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_abstract&amp;pid=S1679-49742022000100703&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_pdf&amp;pid=S1679-49742022000100703&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Objetivo:  Determinar a prevalência e fatores associados à intenção de se vacinar contra a COVID-19 entre idosos brasileiros.  Métodos:  Estudo seccional, baseado em entrevistas telefônicas de participantes do Estudo Longitudinal da Saúde dos Idosos Brasileiros (60 anos ou mais), conduzidas em 70 municípios, em março de 2021. As análises foram realizadas mediante regressão logística multinomial.  Resultados:  Entre 4.364 participantes (idade média = 70,1 anos), 91,8% pretendiam se vacinar ou já haviam sido vacinados, 2,5% não tinham essa intenção e 5,7% estavam indecisos. Residentes do Norte e Sudeste brasileiros apresentaram maiores propensões para se vacinar, assim como aqueles com duas ou mais doenças crônicas. Os que se informam sobre a COVID-19 com amigos/familiares/mídia social foram mais propensos a estarem indecisos acerca da vacinação (odds ratio = 3,15; IC95% 1,28;7,77).  Conclusão:  Identificou-se uma das mais altas prevalências da intenção de se vacinar contra a COVID-19 descritas até a presente data.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo:  Determinar la prevalencia y factores asociados a la intención de vacunarse contra el COVID-19 en ancianos brasileños.  Métodos:  Estudio seccional basado em entrevistas telefónicas con participantes del Estudio longitudinal de la salud del anciano brasileño con 60 años o más, realizadas en 70 municipalidades es en marzo de 2021.  Resultados:  Entre los 4.364 participantes (edad promedio = 70,1 años), el 91,8% tenía la intención de vacunarse o ya lo había hecho, el 2,5% no tienen esta intención y el 5,7% está indeciso. Los residentes de las regiones Norte y Sudeste era más propenso a vacunarse, al igual que aquellos con dos o más enfermedades crónicas. Los que se enteraron del COVID-19 a través de amigos/familiares/redes sociales estaban más indecisos sobre la vacunación (odds ratio = 3,15; IC95% 1,28;7,77).  Conclusión:  Los resultados muestran una de las mayores prevalencias de intención de vacunación contra el COVID-19 descritas en la literatura hasta la fecha.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Objective:  To determine prevalence and factors associated with intention to get vaccinated against COVID-19 among older Brazilians.  Methods:  This was a cross-sectional study based on telephone interviews with participants of the Brazilian Longitudinal Study of Aging (ELSI-Brazil) aged 60 years and over, conducted in 70 municipalities in March 2021.  Results: Among the 4,364 participants (mean age = 70.1 years), 91.8% intended to get vaccinated or had already been vaccinated, 2.5% did not intend to get vaccinated and 5.7% were undecided. Participants living in the North and Southeast regions were more likely to want to get vaccinated, as were those with two or more chronic diseases. Those who learned about COVID-19 from friends/family/social media were more likely to be undecided about vaccination (odds ratio = 3.15; 95%CI 1.28;7.77).  Conclusion: The study identified one of the highest prevalence of intention to get vaccinated against COVID-19 described in the literature to date.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[COVID-19]]></kwd>
<kwd lng="pt"><![CDATA[Vacinas]]></kwd>
<kwd lng="pt"><![CDATA[Recusa de Vacinação]]></kwd>
<kwd lng="pt"><![CDATA[Idosos]]></kwd>
<kwd lng="pt"><![CDATA[Estudos Transversais]]></kwd>
<kwd lng="pt"><![CDATA[Brasil]]></kwd>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[Vacunas]]></kwd>
<kwd lng="es"><![CDATA[Negativa a la Vacunación]]></kwd>
<kwd lng="es"><![CDATA[Anciano]]></kwd>
<kwd lng="es"><![CDATA[Estudios Transversales]]></kwd>
<kwd lng="es"><![CDATA[Brasil]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[Vaccines]]></kwd>
<kwd lng="en"><![CDATA[Vaccination Refusal]]></kwd>
<kwd lng="en"><![CDATA[Aged]]></kwd>
<kwd lng="en"><![CDATA[Cross-Sectional Studies]]></kwd>
<kwd lng="en"><![CDATA[Brazil]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<source><![CDATA[COVID-19 Dashboard by the Center for Systems Science and Engineering at Johns Hopkins University (JHU)]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lesser]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Daly]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2021</year>
<volume>39</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>2024-34</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Ministério da Saúde</collab>
<source><![CDATA[Plano Nacional de Operacionalização. Entenda a ordem de vacinação contra a Covid-19 entre os grupos prioritários]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramasamy]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Minassian]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Ewer]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2020</year>
<volume>396</volume>
<page-range>1979-93</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Voysey]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Clemens]]></surname>
<given-names><![CDATA[SAC]]></given-names>
</name>
<name>
<surname><![CDATA[Madhi]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Weckx]]></surname>
<given-names><![CDATA[LY]]></given-names>
</name>
<name>
<surname><![CDATA[Folegatti]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Aley]]></surname>
<given-names><![CDATA[PK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2021</year>
<volume>397</volume>
<numero>10269</numero>
<issue>10269</issue>
<page-range>99-111</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lima-Costa]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[FB]]></given-names>
</name>
<name>
<surname><![CDATA[Souza Jr]]></surname>
<given-names><![CDATA[PRB]]></given-names>
</name>
<name>
<surname><![CDATA[Neri]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[YAO]]></given-names>
</name>
<name>
<surname><![CDATA[Castro-Costa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Brazilian Longitudinal Study of Aging (ELSI-BRAZIL): objectives and design]]></article-title>
<source><![CDATA[Am J Epidemiol]]></source>
<year>2018</year>
<volume>187</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1345-53</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lima-Costa]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Macinko]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[de Andrade]]></surname>
<given-names><![CDATA[FB]]></given-names>
</name>
<name>
<surname><![CDATA[de Souza Júnior]]></surname>
<given-names><![CDATA[PRB]]></given-names>
</name>
<name>
<surname><![CDATA[de Vasconcellos]]></surname>
<given-names><![CDATA[MTL]]></given-names>
</name>
<name>
<surname><![CDATA[de Oliveira]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Iniciativa ELSI-COVID-19: metodologia do inquérito telefônico sobre coronavírus entre participantes do Estudo Longitudinal da Saúde dos Idosos Brasileiros]]></article-title>
<source><![CDATA[Cad. Saúde Pública]]></source>
<year>2020</year>
<volume>36</volume>
<numero>S3</numero>
<issue>S3</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>Center for Diseases Control and Prevention</collab>
<source><![CDATA[Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Callaghan]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Moghtaderi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lueck]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Hotez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Strych]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Dor]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Correlates and disparities of intention to vaccinate against COVID-19]]></article-title>
<source><![CDATA[Soc Sci Med]]></source>
<year>2021</year>
<volume>272</volume>
<page-range>113638</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Macinko]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Seixas]]></surname>
<given-names><![CDATA[BV]]></given-names>
</name>
<name>
<surname><![CDATA[Mambrini]]></surname>
<given-names><![CDATA[JVM]]></given-names>
</name>
<name>
<surname><![CDATA[Lima-Costa]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Which older Brazilians will accept a COVID-19 vaccine? Cross-sectional evidence from the Brazilian Longitudinal Study of Aging (ELSI-Brazil)]]></article-title>
<source><![CDATA[BMJ Open,]]></source>
<year>2021</year>
<volume>11</volume>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[EEC]]></given-names>
</name>
<name>
<surname><![CDATA[Gayawan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Baptista]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Queiroz]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Spatial pattern of COVID-19 deaths and infections in small areas of Brazil]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2021</year>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
